Rating neurologic impairment in multiple sclerosis
An expanded disability status scale (EDSS)
Abstract
One method of evaluating the degree of neurologic impairment in MS has been the combination of grades (0 = normal to 5 or 6 = maximal impairment) within 8 Functional Systems (FS) and an overall Disability Status Scale (DSS) that had steps from 0 (normal) to 10 (death due to MS). A new Expanded Disability Status Scale (EDSS) is presented, with each of the former steps (1,2,3 … 9) now divided into two (1.0, 1.5, 2.0 … 9.5). The lower portion is obligatorily defined by Functional System grades. The FS are Pyramidal, Cerebellar, Brain Stem, Sensory, Bowel & Bladder, Visual, Cerebral, and Other; the Sensory and Bowel & Bladder Systems have been revised. Patterns of FS and relations of FS by type and grade to the DSS are demonstrated.
Get full access to this article
View all available purchase options and get full access to this article.
Information & Authors
Information
Published In
Copyright
© 1983 by the American Academy of Neurology.
Publication History
Published online: November 1, 1983
Published in print: November 1983
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Mental workload levels of multiple sclerosis patients in the virtual reality environment, Artificial Intelligence and Multimodal Signal Processing in Human-Machine Interaction, (343-362), (2025).https://doi.org/10.1016/B978-0-443-29150-0.00016-0
- Transcranial magnetic stimulation enhances the specificity of multiple sclerosis diagnostic criteria: a critical narrative review, PeerJ, 12, (e17155), (2024).https://doi.org/10.7717/peerj.17155
- A translational MRI approach to validate acute axonal damage detection as an early event in multiple sclerosis, eLife, 13, (2024).https://doi.org/10.7554/eLife.79169
- Effects of Physical Therapy and Dalfampridine on Function and Quality of Life in Nonambulatory Individuals With Multiple Sclerosis: A Randomized Controlled Trial, International Journal of MS Care, 26, 3, (98-103), (2024).https://doi.org/10.7224/1537-2073.2023-063
- Mood Associated With Health- and Social-Care–Related Quality of Life in Patients With Advanced Multiple Sclerosis, International Journal of MS Care, (2024).https://doi.org/10.7224/1537-2073.2023-060
- Validity and Reliability of the Turkish Version of the Patient-Reported Impact of Spasticity Measure in Multiple Sclerosis, International Journal of MS Care, 26, Q3, (194-198), (2024).https://doi.org/10.7224/1537-2073.2023-056
- Smoking and Health-Related Quality of Life in Patients With Multiple Sclerosis From Latin America, International Journal of MS Care, 26, Q3, (187-193), (2024).https://doi.org/10.7224/1537-2073.2023-053
- Multiple Sclerosis, Fatigue, Expanded Disability Status Scale: A Cross-Sectional Exploration of Sleep Efficiency and Quantitative Sleep Parameters, International Journal of MS Care, 26, 2, (57-60), (2024).https://doi.org/10.7224/1537-2073.2022-118
- Occupation-Based Intervention for People With Multiple Sclerosis: A Feasibility Study, International Journal of MS Care, 26, Q3, (254-258), (2024).https://doi.org/10.7224/1537-2073.2022-104
- Hand Grip Strength as a Predictive Tool for Upper Extremity Functionality, Balance, and Quality of Life in People With Multiple Sclerosis, International Journal of MS Care, 26, Q3, (134-139), (2024).https://doi.org/10.7224/1537-2073.2022-030
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.